RGB-5088

BIOLOGICAL2 trials

Sponsors

Hangzhou Reprogenix Bioscience, Inc

Conditions

Diabete MellitusDiabete Type 2Diabetes MellitusDiabetes Mellitus, Type 1

Phase 1

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

RecruitingNCT06731218

Hangzhou Reprogenix Bioscience, IncDiabetes Mellitus, Diabetes Mellitus, Type 1

Start: 2025-02-17End: 2031-12-31Target: 10Updated: 2025-09-15

A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus

Not yet recruitingNCT07794254

Hangzhou Reprogenix Bioscience, IncDiabete Mellitus, Diabete Type 2

Start: 2026-09-30End: 2032-12-30Target: 10Updated: 2026-09-08